Patent · US Active

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

US9000173B2 · kind B2 · utility

7Cited by
19References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2014
Grant dateApr 7, 2015
Priority date—
Expiry dateJul 10, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a compound of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.